Nicholas Lydon
- January 11, 2024
- Biochemist
Quick Facts
| Full Name | Nicholas Lydon |
| Date Of Birth | Feb 27, 1957(1957-02-27) |
| Age | 67 |
| Country | United States |
| Horoscope | Pisces |
Nicholas Lydon Biography
| Birthday | Feb 27 |
| Birth Year | 1957 |
Nicholas Lydon is one of the most popular and richest Biochemist who was born on February 27, 1957 in United States. Nicholas B. Lydon FRS (born 27 February 1957) is a British scientist and entrepreneur. In 2009, he was awarded the Lasker Clinical Award and in 2012 the Japan Prize for the development of Gleevec, also known as Imatinib, a selective BCR-ABL inhibitor for the treatment of chronic myeloid leukaemia (CML), which converted a fatal cancer into a manageable chronic condition.
Nick Lydon played a decisive role in the development of Gleevec (Imatinib), a drug that has saved the lives of thousands of patients with chronic myelogenous leukaemia (CML) and gastrointestinal stromal tumours (GIST). Gleevec revolutionised the field of cancer drug discovery by changing rapidly fatal diseases into easily treatable conditions, and showed that, by targeting an oncogene that is the molecular cause of a specific cancer, the defective cancer cells can be killed without any major side effects on normal cells. The remarkable efficacy of Gleevec profoundly changed the perception of protein kinases as therapeutic targets. From being considered to be virtually “undruggable” in 1994, they have become the pharmaceutical industry’s most popular class of drug target today, accounting for over 50% of cancer drug discovery R&D. The international prizes that Nick Lydon has received include, most recently, the Lasker-DeBakey Clinical Medical Research Award from The Lasker Foundation.
Nicholas Lydon Net Worth
| Net Worth | $5 Million |
| Source Of Income | Biochemist |
| House | Living in own house. |
Nicholas Lydon is one of the richest biochemist from United States. According to our analysis, Wikipedia, Forbes & Business Insider, Nicholas Lydon 's net worth $5 Million. (Last Update: December 11, 2023)
Lydon was educated at Strathallan School near Perth, Scotland. He earned a Bachelor of Science degree in biochemistry from the University of Leeds, England in 1978 and received his PhD in biochemistry from the University of Dundee, Scotland in 1982.
In 1982, Lydon accepted a position with Schering-Plough based in France as Charge de Recherche. Three years later, he moved to Switzerland to work with Ciba-Geigy Pharmaceuticals, with whom he developed Gleevec. In 1997, he established Kinetex Pharmaceuticals in Boston which was acquired by Amgen in 2000, with whom he worked until 2002. Thereafter, he established several companies that continue to develop drugs to treat various conditions.
Height, Weight & Body Measurements
Nicholas Lydon height Not available right now. Gordon weight Not Known & body measurements will update soon.
Who is Nicholas Lydon Dating?
According to our records, Nicholas Lydon is possibily single & has not been previously engaged. As of December 1, 2023, Nicholas Lydon’s is not dating anyone.
Relationships Record : We have no records of past relationships for Nicholas Lydon. You may help us to build the dating records for Nicholas Lydon!
Facts & Trivia
Gordon Ranked on the list of most popular Biochemist. Also ranked in the elit list of famous people born in United States. Nicholas Lydon celebrates birthday on February 27 of every year.